Lisa French - Mallinckrodt Plc Ex Officer
| MNKDelisted Stock | USD 0.46 0.02 4.17% |
Insider
Lisa French is Ex Officer of Mallinckrodt Plc
| Phone | 353 1 696 0000 |
| Web | https://www.mallinckrodt.com |
Lisa French Latest Insider Activity
Tracking and analyzing the buying and selling activities of Lisa French against Mallinckrodt Plc stock is an integral part of due diligence when investing in Mallinckrodt Plc. Lisa French insider activity provides valuable insight into whether Mallinckrodt Plc is net buyers or sellers over its current business cycle. Note, Mallinckrodt Plc insiders must abide by specific rules, including filing SEC forms every time they buy or sell Mallinckrodt Plc'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Lisa French over a year ago Disposition of 134590 shares by Lisa French of Mallinckrodt Plc subject to Rule 16b-3 | ||
Lisa French over a year ago Acquisition by Lisa French of 134590 shares of Mallinckrodt Plc subject to Rule 16b-3 |
Mallinckrodt Plc Management Efficiency
Mallinckrodt Plc's management efficiency ratios could be used to measure how well Mallinckrodt Plc manages its routine affairs as well as how well it operates its assets and liabilities.Mallinckrodt Plc has 3.07 B in debt with debt to equity (D/E) ratio of 1.44, which is OK given its current industry classification. Mallinckrodt Plc has a current ratio of 2.92, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Note however, debt could still be an excellent tool for Mallinckrodt to invest in growth at high rates of return.
Similar Executives
| Showing other executives | INSIDER Age | ||
| David Francisco | Organogenesis Holdings | 59 | |
| Jason Green | Canopy Growth Corp | N/A | |
| Mira Jung | Shuttle Pharmaceuticals | 76 | |
| Zachary IV | SNDL Inc | 47 | |
| Robyn Hunter | Journey Medical Corp | N/A | |
| Andrew Stordeur | SNDL Inc | 44 | |
| Anatoly MD | Shuttle Pharmaceuticals | 81 | |
| Shayne Laidlaw | Cronos Group | N/A | |
| Jimes Sabia | Canopy Growth Corp | 58 | |
| Michael Detlefsen | Aurora Cannabis | 56 | |
| CPA CPA | Journey Medical Corp | 69 | |
| Carlos Cortez | Cronos Group | 51 | |
| Ryan Hellard | SNDL Inc | 36 | |
| Claude Maraoui | Journey Medical Corp | 58 | |
| Rick Savone | Aurora Cannabis | N/A | |
| Robbie Madan | SNDL Inc | 45 | |
| Brian Grow | Organogenesis Holdings | 49 | |
| BA Esq | Organogenesis Holdings | 55 | |
| Zorina Pitkin | Organogenesis Holdings | N/A | |
| Kurt Matheson | Organogenesis Holdings | N/A | |
| Ernest Galvan | Journey Medical Corp | 62 | |
Management Performance
| Return On Equity | -1.11 | |||
| Return On Asset | -0.0029 |
Mallinckrodt Plc Leadership Team
Elected by the shareholders, the Mallinckrodt Plc's board of directors comprises two types of representatives: Mallinckrodt Plc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Mallinckrodt. The board's role is to monitor Mallinckrodt Plc's management team and ensure that shareholders' interests are well served. Mallinckrodt Plc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Mallinckrodt Plc's outside directors are responsible for providing unbiased perspectives on the board's policies.
| CPA CPA, Global Officer | ||
| David Norton, Independent Director | ||
| Hugh ONeill, Executive Vice President and President, Autoimmune and Rare Diseases | ||
| Steven Romano, Executive Vice President and Chief Scientific Officer | ||
| Sigurdur Olafsson, Pres CEO | ||
| Mark Trudeau, CEO and President Director and Member of Portfolio Committee | ||
| Kneeland Youngblood, Independent Director | ||
| Bryan Reasons, Chief Financial Officer, Executive Vice President | ||
| Mark Casey, Executive Vice President and Chief Legal Officer | ||
| JoAnn Reed, Independent Director | ||
| J Carroll, Independent Director | ||
| Lisa French, Ex Officer | ||
| Kassie Harrold, Ex Officer | ||
| Jason Goodson, Exec Devel | ||
| Ian Watkins, Chief Human Resource Officer, Executive Vice President | ||
| Stephen Welch, Ex Generics | ||
| Henriette Nielsen, Ex Officer | ||
| Steven MD, Ex Officer | ||
| Angus Russell, Independent Non-Executive Chairman of the Board | ||
| Paul Carter, Independent Director | ||
| Carlos Paya, Independent Director | ||
| Anne Whitaker, Independent Director | ||
| Mark Tyndall, Chief VP |
Mallinckrodt Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Mallinckrodt Plc a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.11 | |||
| Return On Asset | -0.0029 | |||
| Profit Margin | (0.83) % | |||
| Operating Margin | (0.01) % | |||
| Current Valuation | 2.62 B | |||
| Shares Outstanding | 13.29 M | |||
| Shares Owned By Insiders | 10.09 % | |||
| Shares Owned By Institutions | 96.64 % | |||
| Number Of Shares Shorted | 1.79 M | |||
| Price To Earning | 1.09 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Consideration for investing in Mallinckrodt Stock
If you are still planning to invest in Mallinckrodt Plc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Mallinckrodt Plc's history and understand the potential risks before investing.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |